Dr. Dalbagni – who cares for patients with bladder cancer, kidney cancer, penile cancer, and sarcomas – explains treatments offered at Memorial Sloan-Kettering, which can help patients maintain their quality of life.
Dr. Mulhall, director of Memorial Sloan-Kettering’s Male Sexual and Reproductive Medicine Program, explains common concerns about male sexual health and offers advice for men and their partners.
Dr. Parra, who practices at Memorial Sloan-Kettering Basking Ridge, treats prostate, kidney, and bladder cancers with the goal of extending the lives of patients, and giving them the best possible quality of life.
In a recent discussion as part of Memorial Sloan-Kettering’s CancerSmart lecture series, bladder cancer experts spoke about symptoms, risk factors, and the latest treatment options available.
Dr. Bochner – who specializes in treating people with prostate, bladder, and kidney cancers – discusses the importance of a multidisciplinary team approach to delivering high-quality care.
When new cancer drugs are shown to be largely ineffective, exceptional cases of good outcome may pave the way for new treatments that could benefit a smaller group of patients.
In 2003, Mary McCabe was recruited to lead Memorial Sloan-Kettering Cancer Center’s Cancer Survivorship Initiative and since that time has worked to develop a comprehensive program for cancer survivors, which includes follow-up care, research, and education and training.
Many people undergoing cancer treatment receive some form of radiation therapy to shrink and kill a tumor. A relatively new type of radiation therapy — called image-guided radiation therapy (IGRT) — utilizes high-tech imaging with extremely precise radiation beams, ensuring that radiation targets the tumor, sparing nearby healthy tissue. IGRT can be used to treat many types of cancer, including those that develop in the spine, lung, prostate, brain, bladder, esophagus, liver, and bone.
